Tempus AI agreed to acquire Personalis for $16.25 per share, valuing the deal at ~$1.5B enterprise value (net of Tempus’ existing stake). The all-stock/transaction details weren’t provided here, but the announced price implies a material corporate action for both companies. Overall, this is a modestly positive catalyst tied to growth through consolidation in health technology.
Tempus AI agreed to acquire Personalis for $16.25 per share, valuing the deal at ~$1.5B enterprise value (net of Tempus’ existing stake). The all-stock/transaction details weren’t provided here, but the announced price implies a material corporate action for both companies. Overall, this is a modestly positive catalyst tied to growth through consolidation in health technology.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
